Tuesday’s Top Biotech & Medical Stocks

By admin | January 29, 2008

Submitted by BioHealth Investor

Biotechnology

OPEXA THERAPEUTICS [OPXA] +27.39%
STEMCELLS INC [STEM] +19.09%
CARDIOVASCULAR BIOTH [CVBT.OB] +13.91%
COMPUGEN LTD [CGEN] +13.87%
GTC BIOTHERAP INC [GTCB] +11.65%

Diagnostic Substances

INTERLEUKIN GENETICS [ILI] +9.08%
ABAXIS INC [ABAX] +4.31%
IDEXX LABS [IDXX] +3.72%
SYNTA PHARMACEUTICAL [SNTA] +3.67%
AMAG PHARMACEUTICALS [AMAG] +2.88%

Drug Delivery

PENWEST PHARM CO [PPCO] +26.17%
ELAN CP PLC ADR [ELN] +4.88%
ACURA PHARMACEUTICAL [ACPH.OB] +4.00%
COLUMBIA LABS INC [CBRX] +3.33%
NOVEN PHARMACEUTIC [NOVN] +3.09%

Drug Manufacturers

PROTALEX INC [PRTX.OB] +14.04%
CHATTEM INC [CHTT] +12.50%
GERON CORP [GERN] +10.99%
ARDEA BIOSCIENCES [RDEA] +9.33%
SUCAMPO PHARMA. INC. [SCMP] +8.92%

Drug Related Products

LABOPHARM INC. [DDSS] +20.67%
PRESTIGE BRAND HLGS [PBH] +7.28%
SALIX PHARM DEL [SLXP] +5.71%
MANNATECH INC [MTEX] +4.78%
AUXILIUM PHARMACEUT [AUXL] +4.70%

Generic Drugs

CATALYST PHARMACEUTI [CPRX] +12.24%
HELICOS BIOSCIENCES [HLCS] +5.24%
CARACO PHARMA LABS [CPD] +1.31%
MYLAN INC [MYL] +0.82%
BARR PHARMA INC [BRL] +0.31%

Medical Appliances & Equipment

LANGER INC [GAIT] +20.40%
MEDICALCV INC [MCVI.OB] +19.51%
ZIMMER HOLDINGS INC [ZMH] +13.15%
NORTHSTAR NEUROSCI [NSTR] +11.03%
CANDELA CP [CLZR] +9.81%

Medical Instruments & Supplies

MILESTONE SCIENTIFIC [MLSS.OB] +13.04%
HOME DIAGNOSTICS, IN [HDIX] +8.66%
BIOSPHERE MEDICAL [BSMD] +8.37%
MEMRY CORPORATION [MRY] +7.83%
CRYOCOR, INC. [CRYO] +7.54%

Medical Laboratories & Research

ERESEARCHTECHNOLOG [ERES] +3.63%
PSYCHEMEDICS NEW [PMD] +2.83%
NATL DENTEX CP [NADX] +1.31%
QUEST DIAGNOSTC [DGX] +0.54%
LABORATORY CORP NEW [LH] +0.52%

- Monday’s Top Biotech & Medical Stocks
- Friday’s Top Biotech & Medical Stocks

Visit 1800blogger to see all of our industry leading blogs.

Rating 3.00 out of 5
[?]

We don't know every stock and we want to know your thoughts. Register on Biotech Stocks Blog now and get published within minutes. Before posting, it is recommended that you review our posting guidelines.

Comments